ASCO GUIDELINES Bundle

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475475

Contents of this Issue

Navigation

Page 9 of 9

10 Disclaimer is pocket guide is derived om recommendations in the American Society of Clinical Oncology Guideline. is resource is a practice tool based on ASCO ® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. is pocket guide does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. e practice guidelines and additional information are available at www.asco.org/head-neck-cancer-guidelines. Copyright © 2019 by American Society of Clinical Oncology. All rights reserved. Source Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue T, Weiss J, Yom SS and Holsinger FC. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 Feb 27 doi 10.1200/JCO.18.01921 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2019 All rights reserved ASCONEC1922a ASCO believes that cancer clinical trials are vital to inform medical decisions and improve cancer care and that all patients should have the opportunity to participate. Additional information, which may include data supplements, slide sets, and other clinical tools and resources, is available at www.asco.org/head-neck-cancer-guidelines Abbreviations ASCO, American Society of Clinical Oncology; CT, computed tomography; END, elective neck dissection; FDG, fludeoxyglucose; HNC, Head and neck cancer; HPV, human papillomavirus; MRI, magnetic resonance imaging ; cN0, clinically node negative; cN+, clinically node-positive; PET/CT, positron emission tomography and computed tomography; pN0, pathologically node negative; pN+, pathologically node positive; RT, radiotherapy SCC, squamous cell carcinoma; SCCOC, squamous cell carcinoma of oral cavity; SCCOP, squamous cell carcinoma of the oropharynx; Gy, Gray Recommendation Grading Type Benefit/harm Evidence Quality Strength of Recommendation EB Evidence- based B Benefits outweigh harms H High Strong FC Formal consensus H Harms outweigh benefits I Intermediate Moderate IC Informal consensus B/H Relative balance of benefits and harms L Low Weak Ins Insufficient

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx